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ADAS-CogMachine learning and pattern recognition methods have been used to diagnose Alzheimer's disease (AD) and
mild cognitive impairment (MCI) from individual MRI scans. Another application of such methods is to
predict clinical scores from individual scans. Using relevance vector regression (RVR), we predicted
individuals' performances on established tests from their MRI T1 weighted image in two independent data
sets. From Mayo Clinic, 73 probable AD patients and 91 cognitively normal (CN) controls completed the
Mini-Mental State Examination (MMSE), Dementia Rating Scale (DRS), and Auditory Verbal Learning Test
(AVLT) within 3 months of their scan. Baseline MRI's from the Alzheimer's disease Neuroimaging Initiative
(ADNI) comprised the other data set; 113 AD, 351 MCI, and 122 CN subjects completed the MMSE and
Alzheimer's Disease Assessment Scale—Cognitive subtest (ADAS-cog) and 39 AD, 92 MCI, and 32 CN ADNI
subjects completed MMSE, ADAS-cog, and AVLT. Predicted and actual clinical scores were highly correlated
for the MMSE, DRS, and ADAS-cog tests (Pb0.0001). Training with one data set and testing with another
demonstrated stability between data sets. DRS, MMSE, and ADAS-Cog correlated better than AVLT with
whole brain grey matter changes associated with AD. This result underscores their utility for screening and
tracking disease. RVR offers a novel way to measure interactions between structural changes and
neuropsychological tests beyond that of univariate methods. In clinical practice, we envision using RVR to
aid in diagnosis and predict clinical outcome., Mayo Clinic, 13400 East Shea
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With no single marker yet available, combining different relevant
data is one proposed way to increase diagnostic power for
Alzheimer's disease (AD). In particular, the combination of neuro-
psychological and neuroimaging data makes sense, since preclinical
AD has been associated with both cognitive and imaging changes
(Caselli et al., 2009, 2007; Reiman et al., 1996, 2009; Twamley et al.,2006). After a diagnosis of mild cognitive impairment (MCI) or AD,
the combination of cognitive tests and imaging can be used for both
tracking progression of illness and treatment response. For all of
these purposes, the ideal neuropsychological tests must closely
reﬂect the atrophy patterns of the disease. In this paper we focus on
a novel method to correlate an individual's test score with structural
changes.
The relationship between commonly used cognitive measures and
structural changes with MRI has been previously examined using
voxel-based morphometry (VBM) (Baxter et al., 2006; Jack et al.,
2008b) and region of interest studies (Apostolova et al., 2006;
Duchesne et al., 2009; Fama et al., 1997; Ferrarini et al., 2008; Jack et
al., 2004). Duchesne et al. (2009) demonstrated a relationship
between baseline MRI features and decline in Folstein Mini-Mental
State Exam (MMSE) after 1 year using linear regression modeling
within a volume of interest in subjects with MCI. VBM separately
compares the volume of tissue around each point or voxel of the
whole brain, has the advantage of not being biased to one particular
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for examining group differences. Though VBM can be applied to
single-subject data through comparisons of individual scans with
those in a normal control group (Chetelat et al., 2008), the statistical
assumptions underlying such a procedure are not without problems
so that single-subject analysis with VBM is limited in its scope in
terms of translation to the clinic for individual patients.
Pattern recognition and machine learning methods (Bishop, 2006;
Tipping, 2001; Vapnik, 1998) offer another way to analyze MRI scans
at the single-subject level. Multivariate pattern recognition techni-
ques take into account speciﬁc inter-regional dependencies charac-
teristic of different distributed pathologies, using such information to
help separate the data (Lao et al., 2004). So far, most applications of
pattern recognition to imaging data have been for binary classiﬁca-
tion, where the objective has been to predict which class a subject
belongs to. In particular, support vector machines (SVM) have been
used to classify AD (Davatzikos et al., 2008a,b; Gerardin et al., 2009;
Kloppel et al., 2008; Vemuri et al., 2008) and progression to AD from
MCI (Davatzikos et al., 2009; Plant et al., 2010). In this paper, the
objective is to predict a continuous measure from the MR scans, i.e., a
clinical score of dementia severity, after modeling the probability of
the clinical scores given the data. Evidence suggests that relevance
vector regression (RVR; Tipping, 2001) generally performs well for
such problems. The Pittsburgh brain activity interpretation competi-
tion (http://www.lrdc.pitt.edu/ebc/PBAIC.html) provided objective
comparisons among a number of regression methods, and RVR was
found to perform well for fMRI data. The winning team (C.C. and J.A.
from the current study were on this team; http://www.lrdc.pitt.edu/
ebc/2007/2007.html) as well as one of the second place teams both
used RVR. Recently, Franke et al. (2010) reported using RVR and
support vector regression (SVR) for prediction of age of healthy
subjects fromMR structural scans and found that RVR performed very
well and better than SVR for age predictions.
We applied RVR to the prediction of clinical ratings based on the
MR structural images from two independent data bases and four
commonly used cognitive measures: the MMSE (Folstein et al.,
1975), which examines orientation to time and place, immediate and
delayed recall of three words, attention and calculation, language
and visuo-constructional functions; the Mattis Dementia Rating Scale
(DRS) (Mattis, 1988), which tests the areas of attention, initiation/
perseveration, construction, memory, and conceptualization; the
Alzheimer's Disease Assessment Scale—Cognitive subtest (ADAS-
cog), a global measure encompassing the core symptoms of AD
(Rosen et al., 1984); and Rey's Auditory Verbal Learning Test (AVLT)
(Rey, 1964), a measure of verbal memory. We reasoned that the
cognitive test with the greatest predictive accuracy overall would
closely reﬂect whole brain structural changes associated with AD,
whereas tests measuring a single cognitive domain, e.g., AVLT, would
perform less well.Table 1
Demographic information.
Characteristic SET 1 Mayo Clinic, n=164
AD/MCI/CN (n) 73/0/91
Sex (F/M) 53/111
Age (mean, range) 75.9 (50-92)
Years of Education (mean, range) 14.1 (7-20)
MMSE (mean, range) 25.9 (10-30)
AVLT percent retention (mean, range) 8.4 (2-15)a
DRS total raw score (mean, range) 128.7 (85-144)
ADAS-Cog (mean range) —
Abbreviations: AD=Alzheimer's disease; MCI=Mild Cognitive Impairment; CN=cognitive
Verbal Learning Test; ADAS-Cog=Alzheimer's Disease Assessment Scale—Cognitive subtes
a Percent retention, Mayo's Older Americans Normative Studies (MOANS) standard score
b Percent retention, raw score.Methods
We applied RVR to three sets of subjects. “Set 1” were patients
with probable AD and cognitively normal (CN) controls from the
Mayo Rochester Alzheimer's Disease Research Center (ADRC) and
Mayo Alzheimer's Disease Patient Registry (ADPR) (Petersen et al.,
1990) who had all threeMMSE, DRS, and AVLT scores recorded within
3 months of their MRI scan. Of 200 subjects, 10 scans were excluded
for artifacts and abnormalities. From the remaining 190 subjects, 164
had all three MMSE, DRS, and AVLT scores recorded within 3 months
of the scan. “Set 2” were probable AD, MCI, and CN subjects
downloaded from the freely available Alzheimer's Disease Neuroima-
ging Initiative (ADNI) database (www.loni.ucla.edu/ADNI) who had
both the MMSE and ADAS-Cog scores recorded within 3 months of
their MRI scan. “Set 3” were probable AD, MCI, and CN subjects from
the ADNI database who had all three MMSE, ADAS-Cog, and AVLT
scores recorded within 3 months of their MRI scan. Of 610 subjects
with baseline MRI scans in the ADNI database, 12 were excluded for
artifacts and abnormalities. From the remaining 598 subjects, 586 had
both the MMSE and ADAS-Cog scores recorded (“set 2”) and 163 had
the MMSE, ADAS-Cog, and AVLT recorded (“set 3”). Details of the
group are outlined in Table 1. Because the aim was to pair the score
with the image, rather than distinguish between groups, it was not
necessary to exclude control subjects with MMSEb27 or for patients
and controls to be exactly age and education matched. Subjects were
excluded from analysis if their scan revealed gross structural
abnormalities other than atrophy. In order to be included in this
study, subjects had to have clinical scores recorded within 3 months
of their MRI scan.
Set 1
Participants were 73 patients with probable AD, ranging frommild
to severe (MMSE from 10 to 30, mean 22.3) and 91 CN controls from
the Mayo Rochester ADRC and Mayo ADPR (Petersen et al., 1990). The
diagnosis of probable AD was made according to the DSM-III-R
(American Psychiatric Association, 1987) and NINCDS-ADRDA criteria
for AD (McKhann et al., 1984). Cognitively normal (CN) controls were
deemed to be normal by clinical history and examination, including
eight controls with MMSE scores less than 27.
MR scanswere collected over a period of about 10 yearswith a total
of 14 different scanners. Several software updates occurred at different
times for different scanners. However, a closely followed quality
control program insured uniformity over time. All scanners were
monitored with daily phantom quality checks, which calibrated the
gradients to within ±1 mm over a 240-mm rectangular ﬁeld of view
and with signal to noise and radio frequency transmit gain. All scans
were done on the same platform, General Electric Signa 1.5-T scanners
(T1-weighted image parameters: TR=17.7 to 27 ms, TE=6 to 10 ms,SET 2 ADNI, n=586 Set 3 ADNI, n=163
113/351/122 39/92/32
231/355 61/102
75.1 (55-91) 75.3 (58-88)
15.5 (4-20) 15.4 (4-20)
26.7 (20-30) 26.6 (20-30)
— 75.7 (30-100)b
— —
18.90 (1-50) 19.40 (3-48)
ly normal; ADNI=Alzheimer's Disease Neuroimaging Initiative; AVLT=Rey's Auditory
t; DRS=Dementia Rating Scale; MMSE=Mini-Mental State Exam.
s (Ivnik et al., 1990).
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matrix dimensions=256×192). Themajor hardware elements (body
resonance module gradient coil and birdcage head transmit-receive
volume coil)were unchanged throughout time and across all scanners.
Separate VBM analyses described elsewhere (Stonnington et al., 2008)
showedno signiﬁcant interaction of scanner or upgradewith the effect
of disease.
Patients and controls were matched equally for sex, but controls
were slightly younger than patients (mean age 74.7 vs. 77.3; P=0.04)
and slightly more educated (mean years 14.6 vs. 13.5; P=0.01).
Set 2
The 113 AD, 351 MCI, and 122 CN subjects from the ADNI database
(www.loni.ucla.edu/ADNI) had both MMSE and ADAS-Cog scores
recorded. The primary goal of ADNI has been to test whether serial
MRI, PET, other biological markers, and clinical and neuropsycholog-
ical assessment can be combined tomeasure the progression ofMCI to
early AD.
The general inclusion criteria were those of ADNI (http://
clinicaltrials.gov/show/NCT00106899). According to ADNI clinical
procedures, a diagnosis of AD was made if the subject had an MMSE
score between 20 and 26, a Clinical Dementia Rating scale (Morris,
1993) score of 0.5 or 1, and met NINCDS-ADRDA (McKhann et al.,
1984) criteria for probable Alzheimer's disease. Individuals were
classiﬁed as single-domain amnestic MCI if they satisﬁed the
following criteria: (i) score on the MMSE between 24 and 30; (ii)
Clinical Dementia Rating scale=0.5; (iii) reported memory com-
plaint; (iv) objective memory loss measured by education-adjusted
scores on Wechsler Memory Scale Logical Memory (Wechsler, 1987);
(v) absence of signiﬁcant levels of impairment in other cognitive
domains; (vi) preserved activities of daily life; and (vii) absence of
dementia. Healthy controls had an MMSE score between 24 and 30
and a Clinical Dementia Rating scale score of 0. Whatever the
inclusion group, subjects had a Geriatric Depression Scale score of less
than 6.
Baseline MRI's were downloaded from the ADNI data set. ADNI is a
multicenter project that combines data from 55 participating sites and
includes MRI data from 3 different vendors (GE Healthcare, Philips
Medical Systems, or Siemens Medical Solutions/ http://www.loni.
ucla.edu/ADNI/Data/ADNI_Data.shtml) (Jack et al., 2008a). The
detailed protocol for each scanner is publicly available (http://
www.loni.ucla.edu/ADNI/Research/Cores/). A sophisticated system
for quality control including phantom scanning is in place (Gunter et
al., 2009; Mortamet et al., 2009). The target voxel size is approxi-
mately 1 mm3, with a maximum of 1.5 mm in any one direction. All of
the MRI data in this study were acquired on a 1.5-T scanner.
CN, MCI, and AD were matched for age, but AD patients were less
educated than MCI and CN subjects (mean years of education
AD=14.6, MCI=15.8, CN=15.9, P=0.0006) and the MCI subjects
had more men than the AD subjects (AD=52%, MCI=65%, CN=56%,
P=0.03). Among the MCI subjects, 220 did not convert to AD during
the follow-up period and 131 converted to AD (mean 517.5 days,
range 172 to 1111 days). Spearman's correlation coefﬁcient was used
to compare the correlations of predicted and actual scores with days
until AD conversion and to compare the correlations of years of
education with predication accuracy (predicted score minus the
actual score).
Set 3
Only 39 AD, 92 MCI, and 32 CN subjects from the ADNI database
had all three MMSE, ADAS-Cog, and AVLT scores recorded at baseline.
Age and sex was not signiﬁcantly different in the AD, MCI, and CN
groups, but the AD group was slightly less educated (mean years of
education AD=14.2, MCI=15.8, CN=15.8, P=0.03).Cross-validation of sets 1 and 2
In order to test the stability of the method with independent data
sets, we created a training set with set 1 and tested with set 2 and vice
versa. We also examined the importance of having a wide range of
disease severity represented in the training sets by training and
testing with and without the MCI group.
Image processing (Fig. 1)
Images were visually inspected for artifacts or structural abnor-
malities unrelated to AD. Images were ﬁrstly segmented into white
and grey matter (GM) and cerebrospinal ﬂuid using the “uniﬁed
segmentation” (Ashburner and Friston, 2005) approach in SPM5 for
set 1 and SPM8 for set 2 (Wellcome Trust Centre for Neuroimaging,
Institute of Neurology, UCL, London UK – http://www.ﬁl.ion.ucl.ac.
uk/spm). Then, GM segments were further normalized to a
population template generated from the complete image set using a
diffeomorphic registration algorithm (DARTEL; Ashburner, 2007).
This non-linear warping technique minimizes structural variation
between subjects and has been shown to be more accurate than the
standard approach to normalization implemented in SPM (Ber-
gouignan et al., 2009; Klein et al., 2009). A separate Jacobian
transformation step (often referred to as “modulation”) that multi-
plies the partitioned images by the relative voxel volumes, i.e., the
Jacobian determinants of the deformation ﬁeld (Ashburner and
Friston, 2000), was used to ensure that the overall volume of each
tissue class remained constant after normalization. As in our previous
work using SVM and DARTEL normalization (Kloppel et al., 2008), no
spatial smoothing was performed for our primary analyses because of
the greater accuracy of the DARTEL method. However, a post-hoc
analysis that included spatial smoothingwith a 6-mmGaussian kernel
was performed to conﬁrm this supposition. The voxels in the pre-
processed data served as features for subsequent pattern recognition.
Relevance vector regression
Relevance vector regression (RVR) is a sparse kernel method
formulated in a Bayesian framework (Tipping, 2001; Bishop, 2006).
Unlike typical kernel algorithms such as support vector machines
(SVM), RVR treats the kernel as a set of linear basis functions in order
to obtain the form of equation. ϕ:X*∈ℜD→ϕ(x*)=(k(x*,x1),…,k(x*,
xN))∈ℜN, where k(x1,x2) is the kernel function, D is the dimension-
ality of a feature set, and N is the number of samples. In this particular
work, it is deﬁned as the dot product of two input vectors. The “kernel
matrix” K is generated from the pre-processed image data (i.e.,
spatially normalized and modulated GM segments). The set of
features from each individual subject (in our case, these features
were voxel values) can be considered as a point located in a high
dimensional space, where the number of features determines the
number of dimensions. For linear regression models, the pairwise
similaritymeasures are computed from the dot product of each image,
with every other image. Computing a dot product of an image pair
simply involves multiplying the voxel values of one image by the
values of the corresponding voxels of the other and adding up the
result.
Strictly speaking, RVR is not a kernel algorithm because its input is
not required to be a kernel satisfying Mercer's condition. In other
words, the input matrix need not be symmetric and positive deﬁnite
matrix. It is also possible to take only a few “representative samples”
and use similarity measures, i.e. kernel values, or dissimilarity
measures of these samples as basis functions. The general RVM
takes a full kernel matrix as input and appends a column of ones to
model the offset. In this work, we apply this standard formulation.We
will denote the N by N+1 basis functions by Φ=[l,K], where l is an N
element column vector of ones.
Fig. 1. Flow diagram showing pre-processing steps. Abbreviations: GM=grey matter; WM=white matter; CSF=cerebral spinal ﬂuid; DARTEL=Diffeomorphic Anatomical
Registration Through Exponentiated Lie Algebra.
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Gaussian distribution, p(t|w,σ2)=N(t|Φw,σ2I), where t is the target
variable. Each of the weights, w, are modeled to have a zero mean
Gaussian prior with independent variance αi−1, so the weight prior
is pðw jaÞ = ∏
N
i=0
Nðwi j0; a−1i Þ. Combining the prior and likelihood
functions, yields the posterior distribution over the weights, p(w|
t,α,σ2)=N(w|μ,Σ), where Σ=(σ−2ΦTΦ+A)−1 is the posterior
covariance and A=diag(α0,α1,…,αN) is the diagonal matrix with
the precision, or the inverse of the variance, for each weight. The
equation μ=σ−2ΣΦTt is the maximum posterior weight. In the
Bayesian framework, ﬁnding an optimum solution involves maximizing
the marginal likelihood (type-II maximum likelihood) with respect to
the hyper-parameters α and a noise variance σ2. Because both the
likelihood and the prior are modeled by Gaussian distributions, it is
analytically feasible to derive the marginal likelihood function by
integrating over the parameters (weights). The marginal likelihood isalso a Gaussian pðt jα;σ2Þ = ∫pðt jw;σ2Þpðw jαÞdw = Nðt j0;CÞ,
where C=σ2I+ΦA−1ΦT is the covariance of the marginal likelihood.
The objective of the optimization is to ﬁnd the hyper-parameters, A,σ2,
which maximize the “evidence” of the data. When maximizing the
marginal likelihood, some of the αwill grow very large, implying a small
prior variance. Because the prior is zero mean, a parameter with an
extremely small variance will have its posterior probability sharply
peaked at zero. This property allows irrelevant columns of basic
functions to be pruned out and is known as automatic relevance
determination (ARD) (MacKay, 1995). The parameters with non-zero
weights are called “relevance vectors”, which are analogous to “support
vectors.”
The training step enables an RVR to use basis functions Φ to learn
the relationship between images and corresponding clinical scores.
Fig. 2 is a simpliﬁed illustration of linear regression. With a linear
pattern recognition algorithm, it is possible to learn aweighting image,
Fig. 2. Illustration of relevance vector regressionwith hypothetical 2D training data. The
numbers in the squares are the training targets, i.e., actual scores, and the coordinates
show the value of 2 different voxel intensities (feature 1 and feature 2). The goal is to
ﬁnd the features most predictive of the clinical score. All subjects are projected into a
one-dimensional line in such a way that minimizes the differences between the actual
scores and the scores after projection, i.e., predicted score. For example, box 31 is
projected into a value less than 31, which is the error that needs to be minimized in the
learning algorithm.
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behavioral test scores. The predicted score of a new subject can be
calculated by computing the dot product (sum of element-wise
multiplication) of the weighting image obtained from the training
group and the new subject's pre-processed image (features), then
adding a constant.
In order to evaluate the performance of an RVR, cross-validation
was done by leaving one of the subjects out so that the remaining
subjects (n−1) were used to train the RVR. The clinical rating of the
subject left out was predicted from the corresponding image. This
procedure was repeated for each subject and ﬁnally, a correlation was
calculated between subjects' true clinical scores and the ones
predicted from scan analysis by the RVR method. In addition to the
leave one outmethod, we also cross-validated by trainingwith one set
and testing with an independent data set. The RVR was used to test
whether any of the recorded clinical scores (DRS, MMSE, ADAS-Cog,
and AVLT) separately and signiﬁcantly correlated with structural
changes in the group of AD, MCI, and CN individuals. The aim was to
identify GM structures showing amonotonic relationshipwith clinical
score. The RVR provides a prediction of the clinical score in a given test
that is based on individual brain structure. The predicted and actual
clinical scores were compared using Pearson's correlation coefﬁcient,
a standard technique for measuring linear relationships. The higher
the correlation, the more accurate are the predictions. We also
calculated the root mean square (RMS) of the errors, which are very
close to the standard deviations of the errors if the mean of the errors
are approximately zero. The drawback of using the RMS of the errors
as the measure of prediction accuracy is that different clinical scores
have different scales. In order to compare across different scores, we
normalized the actual scores to have zero means and variances of one.
The higher the normalized RMS, the less accurate are the predictions.
Results
Set 1
For whole brain images, the correlations of predicted and actual
scores were as follows: MMSE: 0.70; DRS: 0.73; AVLT: 0.60. No
improvement in accuracy occurred with spatial smoothing: MMSE:
0.66; DRS: 0.72; AVLT: 0.55. The likelihood of each of these
correlations occurring by chance is Pb0.0001. When restricting
analysis to the 73 AD subjects only, MMSE (r=0.44) and DRS
(r=0.54) correlations remain highly signiﬁcant (Pb0.0001) but notwith AVLT (r=0.16, P=0.17). The RMS of the errors were as follows:
MMSE: 3.22; DRS: 10.24; AVLT: 2.85. The normalized RMS were as
follows: MMSE: 0.72; DRS: 0.69 AVLT: 0.8.
Set 2
Correlations of the predicted and actual scores for the group of
586 subjects with both MMSE and ADAS-Cog baseline scores were as
follows: MMSE: 0.48, Pb0.0001; ADAS-Cog: 0.57, Pb0.0001. As in set
1, no substantial improvement was obtained with spatial smooth-
ing: MMSE r=0.44; ADAS-Cog r=0.58. Prediction accuracy (actual
score minus predicted score) and years of education were signi-
ﬁcantly correlated for both MMSE (r=0.18, Pb0.0001) and ADAS-
Cog (r=−0.16, Pb0.0001). In the subset of 351 MCI subjects, both
the predicted and actual scores signiﬁcantly correlated with days to
conversion to AD (using 1500 days for non-converters): actual
MMSE, r=0.19, P=0.0004; predicted MMSE, r=0.36, Pb0.0001.
Actual ADAS-cog, r=−0.37, Pb0.0001, predicted ADAS-cog, r=
−0.41, Pb0.0001. The RMS of the errors were as follows: MMSE:
2.2; ADAS-Cog: 7.1. The normalized RMS were as follows: MMSE:
0.88; ADAS-Cog: 0.82.
Set 1 and set 2 cross-validation (MMSE)
When set 1 MMSE was used to train and set 2 MMSE without MCI
was used to test, r=0.56, Pb0.0001. Similarly, when set 2 without MCI
was used for training and set 1 was used for testing, r=0.60, Pb0.0001.
Likewise, when training with set 2 (including MCI) and testing with
set 1, r=0.62, Pb0.0001. However, training with set 1 (no MCI) and
testing with set 2 (including MCI) reduced the accuracy to r=0.40.
Set 3
For the subset of subjects with AVLT, MMSE, and ADAS-Cog
(n=163) all recorded, the correlations between predicted and actual
scores were MMSE 0.47 (Pb0.0001), ADAS-Cog 0.49 (Pb0.0001), and
AVLT percent retention 0.13 (P=0.10). With spatial smoothing, the
correlations were MMSE 0.51(Pb0.0001), ADAS-cog 0.48 (Pb0.0001),
and AVLT r=0.17(P=0.03).
Fig. 3 contains the plots of predicted versus actual scores for the
different clinical rating scales. Fig. 4 depicts theweightmaps for whole
brain grey matter images, showing those brain areas most important
for the prediction of clinical score. The RMS of the errors were as
follows: MMSE: 2.19; ADAS-Cog: 7.27; AVLT: 18.97. The normalized
RMS were as follows: MMSE: 0.88; ADAS-Cog: 0.87; AVLT: 1.
In addition to comparing the accuracy of predictions, we also
computed the ratio of relevance vectors (number of non-zero weights
divided by the total number of training samples) of each data set and
scores. The results are listed here: set 1: MMSE, 81.1%; DRS, 82.32%;
AVLT, 98.17%; set 2: MMSE, 86.52%; ADAS-Cog, 99.66%; set 3: MMSE,
98.77%; ADAS-Cog, 98.77%; AVLT, 98.77%.
Discussion
We were able to assess different clinical scores with respect to the
same structural data using RVRs. Our results imply strong linear
relationships between DRS, MMSE, and ADAS-Cog scores and GM
segments of T1 whole brain weighted images, but not with the AVLT.
The normalized RMS results verify that the DRS, closely followed by
MMSE in set 1, and the ADAS-Cog, closely followed by MMSE in sets 2
and 3 provided the best predictions. Whole brain images gave a better
correlation with MMSE, DRS, and ADAS-Cog because they test
multiple domains, unlike the AVLT. The AVLT largely tests the single
domain of memory, which is associated with medial temporal lobe
structures. In this case, brain regions outside this territory may have
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Fig. 4. Weight maps for whole brain images, reﬂecting areas of the brain most vital in determining each RVR score. The red areas indicate where more grey matter adds to the
accuracy of predicted test score, whereas blue areas indicate areas where more grey matter subtracts from the score. Note that dementia does not necessarily cause increased
volumes of grey matter in these blue areas, but simply that data from these regions may help to adjust for anatomical variability (cf. the contribution made by height when
computing body mass index). In contrast to the MMSE and DRS, a lower score indicates better performance for the ADAS-Cog; therefore, these weight maps are mirror images.
AVLT=Rey's Auditory Verbal Learning Test; DRS=Dementia Rating Scale; MMSE=Mini-Mental State Exam; ADAS-Cog=Alzheimer's Disease Assessment Scale—Cognitive Subtest.
1411C.M. Stonnington et al. / NeuroImage 51 (2010) 1405–1413contributed relatively more noise than discriminant signal. Thus, for
prediction of single-domain test scores from structural images, using a
well-placed VOI may prove useful. Set 1 did not include anMCI group;Fig. 3. Whole brain grey matter plots of predicted versus actual scores for 4 different clinica
CN=Cognitively Normal; AVLT=Rey's Auditory Verbal Learning Test; DRS=Dementia
Assessment Scale—Cognitive Subtest.the prediction accuracies may have been inﬂated by the large group of
CN subjects with many scores at ceiling. The correlations were also
likely stronger in set 1 due to inclusion of more severe AD subjects,l ratings. Abbreviations: AD=Alzheimer's disease; MCI=Mild Cognitive Impairment;
Rating Scale; MMSE=Mini-Mental State Exam; ADAS-Cog=Alzheimer's Disease
1412 C.M. Stonnington et al. / NeuroImage 51 (2010) 1405–1413reﬂected by lower MMSE scores. The difference in disease severity
between sets 1 and 2 is also evident when comparing their MMSE
weighted images (Fig. 4). Removing the large group of CN subjects
from set 1 lowered prediction accuracies to more closely reﬂect those
of set 2. Conversely, when set 1 (no MCI group and a more severe AD
group) was used for training and set 2 (large MCI group) was used for
testing, the predication accuracy worsened, probably because com-
parable subjects were missing from the training set.
Demonstration of stability between different data sets is important
for the future clinical use of machine learning methods. Training with
one data set and testing with another demonstrated stability between
them when the training and testing groups were comparable, e.g., set
1 and set 2 with no MCI group, or when the training set included a
wider group than the testing set, e.g., set 2 for training and set 1 for
testing. Therefore, the prediction accuracy correlation is likely more
trustworthy with a distributed range of scores and scans and a large
number of training samples, such as in set 2 with the large group of
MCI subjects in addition to AD and CN subjects. The inclusion of more
severe AD subjects in the training set would likely improve the
performance further due to an even wider range of both scores and
structural changes.
One proposed use of prediction accuracy by RVR is to test howwell
a particular score correlates with structure for any disease. Future
studies should evaluate RVRs of whole brain images with other
instruments, such as the Short-Test of Mental Status (Kokmen et al.,
1987) and the Montreal Cognitive Assessment (Nasreddine et al.,
2005). Using prediction accuracy to determine which of the
commonly used clinical global assessment screens aremost accurately
predicted from brain images of patients with MCI and early AD should
prove a useful validation method of the instrument and might
establish an optimal short battery of screening tests for tracking
disease progression. From the individual patient perspective, this
method may prove useful when clinical score data are not available.
For example, predicting performance on global cognitive screening
tests from an MRI scan may help to distinguish delirium from
dementia in patients presenting to an emergency department with
confusion and no prior records reﬂecting previous mental status.
There are several cautions and limitations when interpreting of
our results. The results of the ratio of relevance vectors suggest that
the training is not very sparse; the low sparsity suggests that
information from many images contributes towards predictions,
which may indicate that more scans would provide additional
information. Even though statistically signiﬁcant, the more modest
correlations with a limited set consisting of only AD or MCI patients
cautions us from drawing ﬁrm conclusions regarding the clinical
signiﬁcance of the procedure at this juncture. Further validation
studies with differing sample sizes and ranges of disease severity
will help to clarify this issue with respect to RVR. We restricted our
analyses to GM segmented images. It is possible that certain clinical
tests reﬂect white matter (WM) changes whereas others reﬂect GM
changes (Baxter et al., 2006). However, analyses using a kernel of
GM plus WM performed on the same data sets did not improve the
accuracy of any predictions. Given that atrophy in GM is a more
established attribute of AD, the WM images likely added more noise
than useful information. Future studies that also incorporate WM
hyperintensities reﬂecting vascular pathology, which is known to
occur in parallel with GM changes, may add more useful informa-
tion. Also, after eliminating subjects whose testing was outside
3 months of a scan, CN subjects were slightly younger than the AD
patients in set 1. However, the contribution from age should be
relatively small, and further univariate analysis of set 1 in which we
removed the effect of age at each voxel by treating it as a
confounding variable improved rather than diminished the correla-
tions (MMSE=0.72, DRS=0.76, and AVLT=0.63). Similarly, the
slight group differences in sex distribution and education in sets 2
and 3 are unlikely to have substantially affected prediction accuracy.Furthermore, comparing prediction accuracy of one clinical test with
another within the same set should not be affected by such a bias,
since the prediction accuracy of each clinical score would be subject
to the same inhomogeneity.
It is possible that for tests showing a good correlation with
structure, the prediction accuracy (the actual score minus the
predicted score) may provide useful clinical information. Since RVR
gives probabilistic predictions, it is possible to measure the distance in
standard deviations between predicted and actual scores. For
example, in those who have learned compensatory strategies or can
tolerate progressive brain pathology without manifesting cognitive
symptoms, i.e., have a greater cognitive reserve (Stern, 2006), the
expectation would be a predicted score lower than the clinical score.
Years of education – one factor thought to provide cognitive reserve –
and the prediction error (actual score minus predicted score) were
signiﬁcantly correlated for the MMSE and ADAS-Cog in the ADNI data
set. It is interesting to note that the 3 obvious outliers in Fig. 3 (set 2)
include 2 MCI subjects, each with 18 years of education: one with an
ADAS-Cog score of 10 but a predicted ADAS-Cog score of 39.04 (actual
MMSE of 28 and predicted MMSE of 23.47) and the other with an
actual MMSE of 29 and predicted MMSE of 23.99 (actual ADAS-Cog of
23.33 and predicted ADAS-Cog of 30.14). Conversely, the third outlier
was a CN subject with 12 years of education, actual MMSE of 25, and
predicted MMSE of 30.68 (actual ADAS-Cog 7.33 and predicted ADAS-
Cog 3.8). Visual inspection of the MRI scans for these subjects reveals
more atrophy in the MCI subjects than the CN subject, indicating that
the predicted score is more reﬂective of brain pathology than actual
scores in these cases, but that factors such as educational level may
have boosted performance on clinical screening tests. Furthermore,
among MCI subjects with an MMSE score of 30, the predicted score
was signiﬁcantly lower in those who subsequently converted to AD
than those who did not (P=0.0006). However, more studies are
needed to assess this method for making predictions about cognitive
reserve that include additional factors such as exercise and leisure
activities, or whether fatigue or depression is a factor in subjects
whose actual test scores are lower than predicted scores, as well as
further evaluation and correction for the possibility that the RVR is
under-estimating higher and over-estimating lower scores.
RVR offers a novel, multivariate method to test speciﬁc inter-
regional dependencies between structural changes and clinical scores.
As expected, and consistent with results from VBM studies, our results
support the utility of the DRS, MMSE, and ADAS-Cog for screening and
tracking AD. Perhaps more intriguing is RVR's ability to aid in making
predictions for individual subjects. In the subset of MCI subjects from
the ADNI data set, correlation of predicted ADAS-Cog or MMSE scores
with days to conversion to AD was not substantially better than the
actual score. Nonetheless, it is possible that other imaging modalities
might work better for this purpose and RVR may well prove useful in
the prediction of imminent disease. Future studies will be directed at
developing and assessing methods to combine clinical scores, with
MRI, PET, and CSF biomarkers for the purpose of predicting clinical
outcome.
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